Papers - OKAMOTO Teppei
-
Pre-transplant tacrolimus fluctuations predict BK virus infection risk in kidney transplants
Hisashi Sakurai, Teppei Okamoto, Anna Yoneyama, Fumiya Yoneyama, Tomoko Hamaya, Hirotake Kodama, Naoki Fujita, Hayato Yamamoto, Kazuyuki Mori, Takeshi Fujita, Atushi Imai, Reiichi Murakami, Hirofumi Tomita,Shingo Hatakeyama, Chikara Ohyama
Clinical and Experimental Nephrology 2025.3
-
パイロット研究；抗癌剤治療を要する進行尿路上皮癌患者を対象とした人参養栄湯によるサルコペニア予防効果の検討（単施設、単群、非盲検化試験）
岡本 哲平
新薬と臨床 73 ( 8 ) 759 - 769 2024.8
-
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8
Kento Morozumi,Koji Mitsuzuka,Shintaro Narita,Masahiro Takahashi,Sadafumi Kawamura,Tatsuo Tochigi,Yoichi Arai,Senji Hoshi,Jiro Shimoda,Shigeto Ishidoya,Teppei Okamoto,Shingo Hatakeyama,Toshihiko Sakurai,Norihiko Tsuchiya,Chikara Ohyama,Tomonori Habuchi,Akihiro Ito
2022.1
-
The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan
Okuyama Y, Okamoto T, Sasaki D, Ozaki K, Songee J, Hatakeyama S, Mikami T, Ohyama C.
International Urology and Nephrology 2021.10
-
Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study
Fukushi K, Okamoto T, Ozaki Y, Ozaki K, Sasaki D, Miura Y, Okuyama Y, Tanaka Y, Imanishi K, Hatakeyama S, Saitoh F, Ohyama C.
Clinical and Experimental Nephrology 2021.9
-
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study
Kai Ozaki, Hayato Yamamoto, Yuya Sekine, Hirotaka Horiguchi, Shogo Hosogoe, Jotaro Mikami, Naoki Fujita, Noriko Tokui, Kazutaka Okita, Teppei Okamoto, Kanami Mori, Mizuki Kobayashi, Kazuyuki Numakura, Takahiro Yoneyama, Ryuji Tabata, Satoshi Sato, Tomonori Habuchi, Chikara Ohyama, Shingo Hatakeyama
International Journal of Clinical Oncology 2025.3
-
Penile metastasis from a duodenal gastrointestinal stromal tumor: A rare case report
Yoneyama F, Okamoto T, Hamaya T, Kodama H, Fujita N, Yamamoto H, Imai A, Hatakeyama S.
Urology Case Reports 2025.2
-
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study
Taigo Kato, Junya Furukawa, Nobuyuki Hinata, Kosuke Ueda, Isao Hara, Fumiya Hongo, Ryuichi Mizuno, Teppei Okamoto, Hiroshi Okuno, Takayuki Ito, Masahiro Kajita, Mototsugu Oya, Yoshihiko Tomita, Nobuo Shinohara, Masatoshi Eto, Hirotsugu Uemura
International Journal of Clinical Oncology 2024.11
-
Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy
International Journal of Urology 31 ( 12 ) 1330 - 1336 2024.8
-
Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab
Hamaya T, Hatakeyama S, Yoneyama T, Tobisawa Y, Kodama H, Fujita T, Murakami R, Mori K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C.
Scientific Reports 2023.9
-
Relationship between lower urinary tract symptoms and frailty
Ozaki Y, Hatakeyama S, Imai A, Songee J, Soma O, Ozaki K, Fujita N, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
International Journal of Urology 2023.4
-
Trends in the age of hospitalized patients with urological cancers: A 17-year experience
Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
International Journal of Urology 2023.3
-
Relationship between lower urinary tract symptoms and frailty
Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
International Journal of Urology 2023.3
-
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Translational Andrology and Urology 2023.2
-
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C
Prostate 2023.2
-
Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
Fujita N, Momota M, Ozaki Y, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
World J Mens Health. 2023.1
-
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study
Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C.
World Journal of Urology 2023.1
-
Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers
Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Cancers 2022.12
-
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study
Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C.
World Journal of Urology 2022.12
-
Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction
Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Urologic Oncology: Seminars and Original Investigations 2022.12